Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika Virus.

Saved in:
Bibliographic Details
Title: Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika Virus.
Authors: Steffen T; Department of Molecular Microbiology and Immunology, Saint Louis University, St Louis, MO 63103, USA., Hassert M; Department of Molecular Microbiology and Immunology, Saint Louis University, St Louis, MO 63103, USA., Hoft SG; Department of Molecular Microbiology and Immunology, Saint Louis University, St Louis, MO 63103, USA., Stone ET; Department of Molecular Microbiology and Immunology, Saint Louis University, St Louis, MO 63103, USA., Zhang J; Altimmune, Inc., Gaithersburg, MD 20878, USA., Geerling E; Department of Molecular Microbiology and Immunology, Saint Louis University, St Louis, MO 63103, USA., Grimberg BT; Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA., Roberts MS; Altimmune, Inc., Gaithersburg, MD 20878, USA., Pinto AK; Department of Molecular Microbiology and Immunology, Saint Louis University, St Louis, MO 63103, USA., Brien JD; Department of Molecular Microbiology and Immunology, Saint Louis University, St Louis, MO 63103, USA.
Source: Vaccines [Vaccines (Basel)] 2020 Apr 07; Vol. 8 (2). Date of Electronic Publication: 2020 Apr 07.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2076-393X
DOI:10.3390/vaccines8020170